Summary
Updated Aug 31, 2026
Troy Edward Wilson is President and CEO, Director of Kura Oncology, Inc. (KURA). 13 SEC Form 4 filings on record going back to 2025, most recently on 24 August 2026. Most recent open-market trade: bought $1.24M of KURA on 24 August 2026. Lifetime open-market purchases: $3.06M. Lifetime open-market sales: $6.16M. Historical track record: 5/5 stars across 3 tracked purchases.
Recent Transactions
20Every recent SEC Form 4 transaction Troy Edward Wilson has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 100% |
| 90-day win rate | 100% |
| Avg 5-day return | +12.25% |
| Avg 30-day return | +30.79% |
| Avg 90-day return | +58.05% |
| Best 30-day return | +42.34% |
Trading Pattern
InsiderAlpha's records for Troy Edward Wilson go back to 2025: 13 primary Form 4 filings, an average of 6.5 per year. The typical open-market purchase is $613K (5 buys totaling $3.06M). The largest single buy on record is $1.24M of KURA in 2026. Sales side: 10 recorded sales totaling $6.16M, so the filing history runs sell-heavy by dollar value. 2 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Troy Edward Wilson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mollie Leoni - $1.19M of KURA open-market activity in the last 12 months
- Teresa Brophy Bair - $691K of KURA open-market activity in the last 12 months
- Brian T. Powl - $398K of KURA open-market activity in the last 12 months
- Alan H. Auerbach - $364K of PBYI open-market activity in the last 12 months
- Francis Burrows - $243K of KURA open-market activity in the last 12 months
- Adrian Senderowicz - $194K of PBYI open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Troy Edward Wilson?
Troy Edward Wilson is a corporate insider, tracked as President and CEO, Director of Kura Oncology, Inc. (KURA). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Troy Edward Wilson submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Troy Edward Wilson been buying or selling stock?
Recorded transactions: 5 open-market purchases ($3.06M) and 10 open-market sales ($6.16M) across all tracked filings.
How accurate is Troy Edward Wilson's historical track record?
Across 3 tracked purchases, Troy Edward Wilson averaged +30.8% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Troy Edward Wilson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Troy Edward Wilson and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial